Copy For Citation
Aydinlar E., Dikmen P., Kosak S., Kocaman A.
The journal of headache and pain, vol.18, no.1, pp.23, 2017 (SCI-Expanded)
Article / Article
The journal of headache and pain
Science Citation Index Expanded (SCI-EXPANDED)
Chronic migraine, Sleep quality, Headache, Analgesic, MIDAS, DASS-21, PREEMPT CLINICAL-PROGRAM, PLACEBO-CONTROLLED PHASE, CHRONIC DAILY HEADACHE, ANXIETY STRESS SCALES, EPISODIC MIGRAINE, OF-LIFE, BOTULINUM-TOXIN, PSYCHOMETRIC PROPERTIES, MEDICATION OVERUSE, DOUBLE-BLIND
Acibadem Mehmet Ali Aydinlar University Affiliated:
Background: OnabotulinumtoxinA (OnabotA) is considered effective in in patients with chronic migraine (CM) who failed on traditional therapies. This study was designed to evaluate the effect of OnabotA injection series on migraine outcome, negative emotional states and sleep quality in patients with CM.